CD52 expression was significantly higher in human NSCLC cell lines, including A549 and NCI-H1299, than in the normal pulmonary bronchial epithelia cell line BEAS-2B (p < 0.001) (Fig. S1A). This evidence concerns the gene CD52 and non-small cell lung carcinoma.